| 1 |
Becker BF. Towards the physiological function of uric acid [J]. Free Radic Biol Med, 1993, 14(6): 615-631.
|
| 2 |
Johnson RJ, Segal MS, Sautin Y, et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease [J]. Am J Clin Nutr, 2007, 86(4): 899-906.
|
| 3 |
袁若圳, 吴思缈, 吴波, 等. 重视中国脑卒中负担地域差异及西南地区现状 [J]. 华西医学, 2019, 34(10): 1083-1086.
|
| 4 |
Lehto S, Niskanen L, Rönnemaa T, et al. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus [J]. Stroke, 1998, 29(3): 635-639.
|
| 5 |
Culleton BF, Larson MG, Kannel WB, et al. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study [J]. Ann Intern Med, 1999, 131(1): 7-13.
|
| 6 |
Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey [J]. JAMA, 2000, 283(18): 2404-2410.
|
| 7 |
Bos MJ, Koudstaal PJ, Hofman A, et al. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study [J]. Stroke, 2006, 37(6): 1503-1507.
|
| 8 |
Hozawa A, Folsom AR, Ibrahim H, et al. Serum uric acid and risk of ischemic stroke: the ARIC Study [J]. Atherosclerosis, 2006, 187(2): 401-407.
|
| 9 |
Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? [J]. Hypertension, 2003, 41(6): 1183-1190.
|
| 10 |
Jiménez MC, Curhan GC, Choi HK, et al. Plasma uric acid concentrations and risk of ischaemic stroke in women [J]. Eur J Neurol, 2016, 23(7): 1158-1164.
|
| 11 |
Wang L, Hu W, Miao D, et al. Relationship between serum uric acid and ischemic stroke in a large type 2 diabetes population in China: a cross-sectional study [J]. J Neurol Sci, 2017, 376(176-180).
|
| 12 |
Shi J, Yan G, Cao L, et al. The contribution of plasma uric acid to the risk of stroke in hypertensive populations [J]. Cardiovasc J Afr, 2020, 31(6):298-303.
|
| 13 |
Keenan T, Zhao W, Rasheed A, et al. Causal assessment of serum urate levels in cardiometabolic diseases through a mendelian randomization study [J]. J Am Coll Cardiol, 2016, 67(4): 407-416.
|
| 14 |
Ruggiero C, Cherubini A, Ble A, et al. Uric acid and inflammatory markers [J]. Eur Heart J, 2006, 27(10): 1174-1181.
|
| 15 |
Kimura Y, Yanagida T, Onda A, et al. Soluble uric acid promotes atherosclerosis via AMPK (AMP-activated protein kinase)-mediated inflammation [J]. Arterioscler Thromb Vasc Biol, 2020, 40(3): 570-582.
|
| 16 |
Busso N, So A. Mechanisms of inflammation in gout [J]. Arthritis Res Ther, 2010, 12(2): 206.
|
| 17 |
Zimmer S, Grebe A, Latz E. Danger signaling in atherosclerosis [J]. Circ Res, 2015, 116(2): 323-340.
|
| 18 |
Singh JA, Yu S. Allopurinol and the risk of stroke in older adults receiving medicare [J]. BMC Neurol, 2016, 16(1): 164.
|
| 19 |
Kok VC, Horng JT, Chang WS, et al. Allopurinol therapy in gout patients does not associate with beneficial cardiovascular outcomes: a population-based matched-cohort study [J]. PLoS One, 2014, 9(6): e99102.
|
| 20 |
Zhang M, Solomon DH, Desai RJ, et al. Assessment of cardiovascular risk in older patients with gout initiating febuxostat versus allopurinol: population-based cohort study [J]. Circulation, 2018, 138(11): 1116-1126.
|
| 21 |
Weir CJ, Muir SW, Walters MR, et al. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke [J]. Stroke, 2003, 34(8): 1951-1956.
|
| 22 |
Karagiannis A, Mikhailidis DP, Tziomalos K, et al. Serum uric acid as an independent predictor of early death after acute stroke [J]. Circ J, 2007, 71(7): 1120-1127.
|
| 23 |
Dawson J, Lees KR, Weir CJ, et al. Baseline serum urate and 90-day functional outcomes following acute ischemic stroke [J]. Cerebrovasc Dis, 2009, 28(2): 202-203.
|
| 24 |
Zhang X, Huang ZC, Lu TS, et al. Prognostic significance of uric acid levels in ischemic stroke patients [J]. Neurotox Res, 2016, 29(1): 10-20.
|
| 25 |
Chamorro A, Obach V, Cervera A, et al. Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke [J]. Stroke, 2002, 33(4): 1048-1052.
|
| 26 |
Zhang B, Gao C, Yang N, et al. Is elevated SUA associated with a worse outcome in young Chinese patients with acute cerebral ischemic stroke? [J]. BMC Neurol, 2010, 10:82.
|
| 27 |
Naganuma M, Inatomi Y, Nakajima M, et al. Associations between uric acid level and 3-month functional outcome in acute ischemic stroke patients treated with/without edaravone [J]. Cerebrovasc Dis, 2018, 45(3-4): 115-123.
|
| 28 |
Wang Z, Lin Y, Liu Y, et al. Serum uric acid levels and outcomes after acute ischemic stroke [J]. Mol Neurobiol, 2016, 53(3): 1753-1759.
|
| 29 |
Amaro S, Soy D, Obach V, et al. A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke [J]. Stroke, 2007, 38(7): 2173-2175.
|
| 30 |
Chamorro A, Amaro S, Castellanos M, et al. Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial [J]. Lancet Neurol, 2014, 13(5): 453-460.
|
| 31 |
Chamorro Á, Amaro S, Castellanos M, et al. Uric acid therapy improves the outcomes of stroke patients treated with intravenous tissue plasminogen activator and mechanical thrombectomy [J]. Int J Stroke, 2017, 12(4): 377-382.
|
| 32 |
Hong JM, Bang OY, Chung CS, et al. Influence of recanalization on uric acid patterns in acute ischemic stroke [J]. Cerebrovasc Dis, 2010, 29(5): 431-439.
|
| 33 |
Chamorro Á, Lo EH, Renú A, et al. The future of neuroprotection in stroke [J]. J Neurol Neurosurg Psychiatry, 2021, 92(2):129-135.
|
| 34 |
张明, 李健. 尿酸的双重性生物学功能与脑梗死相关性研究进展 [J]. 川北医学院学报, 2015, 30(2): 266-272.
|
| 35 |
Proctor PH. Uric acid: neuroprotective or neurotoxic? [J]. Stroke, 2008, 39(5): e88; author reply e89.
|
| 36 |
Battelli MG, Polito L, Bolognesi A. Xanthine oxidoreductase in atherosclerosis pathogenesis: not only oxidative stress [J]. Atherosclerosis, 2014, 237(2): 562-567.
|
| 37 |
Puddu P, Puddu GM, Cravero E, et al. Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications [J]. J Cardiol, 2012, 59(3): 235-242.
|
| 38 |
Yu ZF, Bruce-Keller AJ, Goodman Y, et al. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo [J]. J Neurosci Res, 1998, 53(5): 613-625.
|
| 39 |
Romanos E, Planas AM, Amaro S, et al. Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke [J]. J Cereb Blood Flow Metab, 2007, 27(1): 14-20.
|
| 40 |
Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension [J]. Eur Heart J, 2018, 39(33): 3021-3104.
|